Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
8.05
+0.25 (3.21%)
Dec 19, 2024, 11:08 AM EST - Market open
Company Description
Scienture Holdings, Inc. operates as health services IT company.
It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics, and independent pharmacies.
Scienture Holdings, Inc. is headquartered in Tampa, Florida.
Scienture Holdings, Inc.
| Country | United States |
| Founded | 2010 |
| IPO Date | Feb 13, 2020 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 19 |
| CEO | Surendra Ajjarapu |
Contact Details
Address: 6308 Benjamin Rd, Suite 708 Tampa, Florida 33634 United States | |
| Phone | (800) 261-0281 |
| Website | scienture.com |
Stock Details
| Ticker Symbol | SCNX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001382574 |
| ISIN Number | US80880X1046 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Surendra K. Ajjarapu | Chief Executive Officer, Secretary and Chairman |
| Prashant Patel R.Ph. | Interim Chief Financial Officer, Interim Principal Accounting Officer, President, Chief Operating Officer and Director |
| Rahul Surana M.B.A., Ph.D. | Executive Vice President and Chief Operating Officer of Scienture LLC |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 3, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Nov 26, 2024 | 8-K | Current Report |
| Nov 6, 2024 | 10-Q | Quarterly Report |
| Nov 6, 2024 | 1-A/A | Filing |
| Oct 11, 2024 | 8-K | Current Report |
| Oct 8, 2024 | 8-K | Current Report |
| Sep 25, 2024 | 1-A | Filing |
| Sep 24, 2024 | 8-K | Current Report |
| Aug 28, 2024 | DEF 14C | Filing |
| Aug 16, 2024 | PRE 14C | Filing |